You are here

  • Home
  • Archive
  • Volume 34, Issue 1
  • Safety and related factors of treatment with long-term atypical antipsychotic in Chinese patients with schizophrenia: observational study

Article info

Article menu

Download PDFPDF

XML
Research methods in psychiatry
Safety and related factors of treatment with long-term atypical antipsychotic in Chinese patients with schizophrenia: observational study

Authors

  • Wenjuan Yu Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China PubMed articlesGoogle scholar articles
  • Jingjing Huang Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China PubMed articlesGoogle scholar articles
  • Sidi He Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China PubMed articlesGoogle scholar articles
  • Lei Zhang Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China PubMed articlesGoogle scholar articles
  • Yifeng Shen Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShanghai Clinical Research Center for Mental Health, Shanghai, China PubMed articlesGoogle scholar articles
  • Huafang Li Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShanghai Clinical Research Center for Mental Health, Shanghai, ChinaShanghai Key Laboratory of Psychotic Disorders, Shanghai, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Huafang Li; lhlh_5{at}163.com
View Full Text

Citation

Yu W, Huang J, He S, et al
Safety and related factors of treatment with long-term atypical antipsychotic in Chinese patients with schizophrenia: observational study
General Psychiatry 2021;34:e100289. doi: 10.1136/gpsych-2020-100289

Publication history

  • Received June 7, 2020
  • Revision received November 10, 2020
  • Accepted November 27, 2020
  • First published February 8, 2021.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.